Global Targeted Anti-Cancer Drug Market Research Report 2017

August 2017 | 111 pages | ID: G9C066DF19FEN
QYResearch

Abstracts

In this report, the global Targeted Anti-Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Targeted Anti-Cancer Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Targeted Anti-Cancer Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Roche
• Eli Lilly
• Celgene
• Sanofi
• eisai
• Sumitomo Dainippon Pharma
• Merck
• Seattle Genetics
• Takeda
• Haosoh Pharma
• Novartis
• Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Injection
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Targeted Anti-Cancer Drug for each application, including

• Breast?Cancer
• Blood Cancer
• Prostate?Cancer
• Respiratory/Lung?Cancer
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Targeted Anti-Cancer Drug Market Research Report 2017

1 TARGETED ANTI-CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Targeted Anti-Cancer Drug
1.2 Targeted Anti-Cancer Drug Segment by Type (Product Category)
  1.2.1 Global Targeted Anti-Cancer Drug Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Targeted Anti-Cancer Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Injection
  1.2.5 Other
1.3 Global Targeted Anti-Cancer Drug Segment by Application
  1.3.1 Targeted Anti-Cancer Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Breast?Cancer
  1.3.3 Blood Cancer
  1.3.4 Prostate?Cancer
  1.3.5 Respiratory/Lung?Cancer
  1.3.6 Other
1.4 Global Targeted Anti-Cancer Drug Market by Region (2012-2022)
  1.4.1 Global Targeted Anti-Cancer Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Targeted Anti-Cancer Drug (2012-2022)
  1.5.1 Global Targeted Anti-Cancer Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Targeted Anti-Cancer Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL TARGETED ANTI-CANCER DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Targeted Anti-Cancer Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Targeted Anti-Cancer Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Targeted Anti-Cancer Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Targeted Anti-Cancer Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Targeted Anti-Cancer Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Targeted Anti-Cancer Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Targeted Anti-Cancer Drug Market Competitive Situation and Trends
  2.5.1 Targeted Anti-Cancer Drug Market Concentration Rate
  2.5.2 Targeted Anti-Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL TARGETED ANTI-CANCER DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Targeted Anti-Cancer Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Targeted Anti-Cancer Drug Production and Market Share by Region (2012-2017)
3.3 Global Targeted Anti-Cancer Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL TARGETED ANTI-CANCER DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Targeted Anti-Cancer Drug Consumption by Region (2012-2017)
4.2 North America Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Targeted Anti-Cancer Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL TARGETED ANTI-CANCER DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Targeted Anti-Cancer Drug Production and Market Share by Type (2012-2017)
5.2 Global Targeted Anti-Cancer Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Targeted Anti-Cancer Drug Price by Type (2012-2017)
5.4 Global Targeted Anti-Cancer Drug Production Growth by Type (2012-2017)

6 GLOBAL TARGETED ANTI-CANCER DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Targeted Anti-Cancer Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Targeted Anti-Cancer Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL TARGETED ANTI-CANCER DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Roche Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Eli Lilly Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Celgene Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Sanofi
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Sanofi Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 eisai
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 eisai Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sumitomo Dainippon Pharma
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sumitomo Dainippon Pharma Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Merck
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Merck Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Seattle Genetics
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Seattle Genetics Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Takeda
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Takeda Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Haosoh Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Targeted Anti-Cancer Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Haosoh Pharma Targeted Anti-Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Novartis
7.12 Pfizer

8 TARGETED ANTI-CANCER DRUG MANUFACTURING COST ANALYSIS

8.1 Targeted Anti-Cancer Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Targeted Anti-Cancer Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Targeted Anti-Cancer Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Targeted Anti-Cancer Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL TARGETED ANTI-CANCER DRUG MARKET FORECAST (2017-2022)

12.1 Global Targeted Anti-Cancer Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Targeted Anti-Cancer Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Targeted Anti-Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Targeted Anti-Cancer Drug Price and Trend Forecast (2017-2022)
12.2 Global Targeted Anti-Cancer Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Targeted Anti-Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Targeted Anti-Cancer Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Targeted Anti-Cancer Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Targeted Anti-Cancer Drug
Figure Global Targeted Anti-Cancer Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Targeted Anti-Cancer Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Targeted Anti-Cancer Drug Consumption (K Units) by Applications (2012-2022)
Figure Global Targeted Anti-Cancer Drug Consumption Market Share by Applications in 2016
Figure Breast?Cancer Examples
Table Key Downstream Customer in Breast?Cancer
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Prostate?Cancer Examples
Table Key Downstream Customer in Prostate?Cancer
Figure Respiratory/Lung?Cancer Examples
Table Key Downstream Customer in Respiratory/Lung?Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Targeted Anti-Cancer Drug Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Targeted Anti-Cancer Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Targeted Anti-Cancer Drug Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Targeted Anti-Cancer Drug Major Players Product Capacity (K Units) (2012-2017)
Table Global Targeted Anti-Cancer Drug Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Targeted Anti-Cancer Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Targeted Anti-Cancer Drug Capacity (K Units) of Key Manufacturers in 2016
Figure Global Targeted Anti-Cancer Drug Capacity (K Units) of Key Manufacturers in 2017
Figure Global Targeted Anti-Cancer Drug Major Players Product Production (K Units) (2012-2017)
Table Global Targeted Anti-Cancer Drug Production (K Units) of Key Manufacturers (2012-2017)
Table Global Targeted Anti-Cancer Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Targeted Anti-Cancer Drug Production Share by Manufacturers
Figure 2017 Targeted Anti-Cancer Drug Production Share by Manufacturers
Figure Global Targeted Anti-Cancer Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Targeted Anti-Cancer Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Targeted Anti-Cancer Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Targeted Anti-Cancer Drug Revenue Share by Manufacturers
Table 2017 Global Targeted Anti-Cancer Drug Revenue Share by Manufacturers
Table Global Market Targeted Anti-Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Targeted Anti-Cancer Drug Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Targeted Anti-Cancer Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Targeted Anti-Cancer Drug Product Category
Figure Targeted Anti-Cancer Drug Market Share of Top 3 Manufacturers
Figure Targeted Anti-Cancer Drug Market Share of Top 5 Manufacturers
Table Global Targeted Anti-Cancer Drug Capacity (K Units) by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Capacity Market Share by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Targeted Anti-Cancer Drug Capacity Market Share by Region
Table Global Targeted Anti-Cancer Drug Production by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Production (K Units) by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Targeted Anti-Cancer Drug Production Market Share by Region
Table Global Targeted Anti-Cancer Drug Revenue (Million USD) by Region (2012-2017)
Table Global Targeted Anti-Cancer Drug Revenue Market Share by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Targeted Anti-Cancer Drug Revenue Market Share by Region
Figure Global Targeted Anti-Cancer Drug Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Targeted Anti-Cancer Drug Consumption (K Units) Market by Region (2012-2017)
Table Global Targeted Anti-Cancer Drug Consumption Market Share by Region (2012-2017)
Figure Global Targeted Anti-Cancer Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Targeted Anti-Cancer Drug Consumption (K Units) Market Share by Region
Table North America Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Targeted Anti-Cancer Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Targeted Anti-Cancer Drug Production (K Units) by Type (2012-2017)
Table Global Targeted Anti-Cancer Drug Production Share by Type (2012-2017)
Figure Production Market Share of Targeted Anti-Cancer Drug by Type (2012-2017)
Figure 2016 Production Market Share of Targeted Anti-Cancer Drug by Type
Table Global Targeted Anti-Cancer Drug Revenue (Million USD) by Type (2012-2017)
Table Global Targeted Anti-Cancer Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Targeted Anti-Cancer Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Targeted Anti-Cancer Drug by Type
Table Global Targeted Anti-Cancer Drug Price (USD/Unit) by Type (2012-2017)
Figure Global Targeted Anti-Cancer Drug Production Growth by Type (2012-2017)
Table Global Targeted Anti-Cancer Drug Consumption (K Units) by Application (2012-2017)
Table Global Targeted Anti-Cancer Drug Consumption Market Share by Application (2012-2017)
Figure Global Targeted Anti-Cancer Drug Consumption Market Share by Applications (2012-2017)
Figure Global Targeted Anti-Cancer Drug Consumption Market Share by Application in 2016
Table Global Targeted Anti-Cancer Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Targeted Anti-Cancer Drug Consumption Growth Rate by Application (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Roche Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Roche Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Eli Lilly Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Eli Lilly Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Celgene Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Celgene Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Sanofi Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Sanofi Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table eisai Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure eisai Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure eisai Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure eisai Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Dainippon Pharma Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sumitomo Dainippon Pharma Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Sumitomo Dainippon Pharma Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Sumitomo Dainippon Pharma Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Merck Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Merck Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Seattle Genetics Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Seattle Genetics Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Takeda Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Takeda Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Haosoh Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Haosoh Pharma Targeted Anti-Cancer Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Haosoh Pharma Targeted Anti-Cancer Drug Production Growth Rate (2012-2017)
Figure Haosoh Pharma Targeted Anti-Cancer Drug Production Market Share (2012-2017)
Figure Haosoh Pharma Targeted Anti-Cancer Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Targeted Anti-Cancer Drug
Figure Manufacturing Process Analysis of Targeted Anti-Cancer Drug
Figure Targeted Anti-Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Targeted Anti-Cancer Drug Major Manufacturers in 2016
Table Major Buyers of Targeted Anti-Cancer Drug
Table Distributors/Traders List
Figure Global Targeted Anti-Cancer Drug Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Targeted Anti-Cancer Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Targeted Anti-Cancer Drug Production (K Units) Forecast by Region (2017-2022)
Figure Global Targeted Anti-Cancer Drug Production Market Share Forecast by Region (2017-2022)
Table Global Targeted Anti-Cancer Drug Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Targeted Anti-Cancer Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Targeted Anti-Cancer Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Targeted Anti-Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Targeted Anti-Cancer Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Targeted Anti-Cancer Drug Production (K Units) Forecast by Type (2017-2022)
Figure Global Targeted Anti-Cancer Drug Production (K Units) Forecast by Type (2017-2022)
Table Global Targeted Anti-Cancer Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Targeted Anti-Cancer Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Targeted Anti-Cancer Drug Price Forecast by Type (2017-2022)
Table Global Targeted Anti-Cancer Drug Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Targeted Anti-Cancer Drug Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source